Synergistic antimicrobial activity of bacteriophages and antibiotics against Staphylococcus aureus

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Food Science and Biotechnology

• Publication date

  2016-06-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10068-016-0153-0PMID 30263357PMCID PMC6049171
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Temperate and lytic bacteriophages programmed to sensitize and kill antibiotic-resistant bacteria

  2015cited by this paper
• Antibiotic Discovery: Combatting Bacterial Resistance in Cells and in Biofilm Communities

  2015cited by this paper
• Antibiotic resistance: An infectious arms race

  2014cited by this paper
• Phage therapy and phage control: to be revisited urgently!!

  2014cited by this paper
• Facing Antibiotic Resistance: Staphylococcus aureus Phages as a Medical Tool

  2014cited by this paper
• Burkholderia cepacia Complex Phage-Antibiotic Synergy (PAS): Antibiotics Stimulate Lytic Phage Activity

  2014cited by this paper
• Bacteriophage therapy: a potential solution for the antibiotic resistance crisis.

  2014cited by this paper
• Effect of Bacteriophage Infection in Combination with Tobramycin on the Emergence of Resistance in Escherichia coli and Pseudomonas aeruginosa Biofilms

  2014cited by this paper
• Efficacy of bacteriophage LISTEX™P100 combined with chemical antimicrobials in reducing Listeria monocytogenes in cooked turkey and roast beef.

  2013cited by this paper
• Phage-antibiotic synergism: a possible approach to combatting Pseudomonas aeruginosa.

  2013influential reference
• Synergistic Action of Gentamicin and Bacteriophage in a Continuous Culture Population of Staphylococcus aureus

  2012influential reference
• Methicillin-Resistant Staphylococcus aureus Phage Plaque Size Enhancement Using Sublethal Concentrations of Antibiotics

  2012cited by this paper
• Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogens

  2011cited by this paper
• Exploiting what phage have evolved to control gram-positive pathogens

  2011cited by this paper
• Meeting the challenges of methicillin-resistant Staphylococcus aureus with outpatient parenteral antimicrobial therapy.

  2010cited by this paper
• Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe.

  2010cited by this paper
• DETECTION OF ANTIMICROBIAL RESISTANCE IN COMMON GRAM NEGATIVE AND GRAM POSITIVE BACTERIA ENCOUNTERED IN INFECTIOUS DISEASES – AN UPDATE

  2009cited by this paper
• Staphylococcus aureus infections.

  2009cited by this paper
• Defining Fractional Inhibitory Concentration Index Cutoffs for Additive Interactions Based on Self-Drug Additive Combinations, Monte Carlo Simulation Analysis, and In Vitro-In Vivo Correlation Data for Antifungal Drug Combinations against Aspergillus fumigatus

  2009cited by this paper
• Phage-Antibiotic Synergy (PAS): β-Lactam and Quinolone Antibiotics Stimulate Virulent Phage Growth

  2007influential reference
• Genomewide screens for Escherichia coli genes affecting growth of T7 bacteriophage

  2006cited by this paper
• Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard

  2000cited by this paper
• Staphylococcus aureus infections.

  1998cited by this paper
• Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically

  1990cited by this paper
• Differences in susceptibility to quinolones of outer membrane mutants of Salmonella typhimurium and Escherichia coli

  1986cited by this paper

• Staphylococcal phages as agents of evolution and innovation: From gene flow to next-generation therapeutics

  2026cites this paper
• Biological treatments for zoonotic salmonellosis: an evolving therapeutic landscape.

  2026cites this paper
• Pharmacological evaluation of phage-antibiotic synergism against clinical isolates of multi-drug resistant Staphylococcus aureus in a burn-induced infection mouse model

  2025cites this paper
• Phage-Antibiotic Synergy Review: Mechanisms, Applications, and Future Prospects

  2025cites this paper
• Phage‐Antibiotic Combinations for Pseudomonas: Successes in the Clinic and In Vitro Tenuously Connected

  2025cites this paper
• Phage Therapy in Aquaculture: Applications, Efficacy and Challenges

  2025cites this paper
• One-Two Punch: Phage-Antibiotic Synergy Observed against Staphylococcus aureus by Combining Pleurotin and Phage K

  2025cites this paper
• Synergistic effects of zP-1 phage and ampicillin against methicillin-resistant Staphylococcus aureus isolated from hospital staff

  2025cites this paper
• Enhanced anti-P. aeruginosa treatment via phage and ciprofloxacin co-loaded particles prepared by electrospraying.

  2025cites this paper
• Optimizing in vitro phage-ciprofloxacin combination formulation for respiratory therapy of multi-drug resistant Pseudomonas aeruginosa Infections.

  2024cites this paper
• Response of Staphylococcus aureus to combination of virulent bacteriophage vB_SauM-515A1 and linezolid

  2024cites this paper
• Temperate phage-antibiotic synergy is widespread—extending to Pseudomonas—but varies by phage, host strain, and antibiotic pairing

  2024cites this paper
• Genomic overview of the N4-like TEMp-D1 phage and the efficacy of antibiotic-phage synergy for the biocontrol of Photobacterium damselae subsp. damselae

  2024cites this paper
• Phage-antibiotic synergy suppresses resistance emergence of Klebsiella pneumoniae by altering the evolutionary fitness

  2024cites this paper
• Temperate phage-antibiotic synergy is widespread, but varies by phage, host, and antibiotic pairing

  2024cites this paper
• Therapeutic Strategies to Combat Increasing Rates of Multidrug Resistant Pathogens

  2024cites this paper
• Emerging roles of bacteriophage-based therapeutics in combating antibiotic resistance

  2024cites this paper
• Evaluation of phage—antibiotic combinations in the treatment of extended-spectrum β-lactamase-producing Salmonella enteritidis strain PT1

  2023cites this paper
• Bacteriophages: The promising therapeutic approach for enhancing ciprofloxacin efficacy against bacterial infection

  2023cites this paper
• Exploiting phage-antibiotic synergies to disrupt Pseudomonas aeruginosa PAO1 biofilms in the context of orthopedic infections

  2023cites this paper
• Response Surface Methodology Application for Bacteriophage–Antibiotic Antibiofilm Activity Optimization

  2023cites this paper
• A novel lytic phage exhibiting a remarkable in vivo therapeutic potential and higher antibiofilm activity against Pseudomonas aeruginosa

  2023influential citation
• Potential application of lactic acid bacteria for controlling discoloration in tuna (Thunnus orientalis)

  2023cites this paper
• A review on biofilms and the currently available antibiofilm approaches: Matrix-destabilizing hydrolases and anti-bacterial peptides as promising candidates for the food industries.

  2022cites this paper
• Synergistic Effects of Phage-Antibiotic Combinations against Citrobacter amalonaticus.

  2022cites this paper
• Bacteriophage therapy in aquaculture: current status and future challenges

  2022cites this paper
• Bacteriophages and antibiotic interactions in clinical practice: what we have learned so far

  2022cites this paper
• WPI Hydrogels with a Prolonged Drug-Release Profile for Antimicrobial Therapy

  2022cites this paper
• PhageScore-based analysis of Acinetobacter baumannii infecting phages antibiotic interaction in liquid medium

  2022cites this paper
• Activity of Phage–Lactoferrin Mixture against Multi Drug Resistant Staphylococcus aureus Biofilms

  2022cites this paper
• The Combination of Salmonella Phage ST-3 and Antibiotics to Prevent Salmonella Typhimurium In Vitro

  2022cites this paper
• Antibiotic resistant bacteria: A bibliometric review of literature

  2022cites this paper
• Double-Layer Agar (DLA) Modifications for the First Step of the Phage-Antibiotic Synergy (PAS) Identification

  2021cites this paper
• Novel Synergistic Approaches of Nano-Biomaterials and Bacteriophage for Combating Antimicrobial Resistance

  2021cites this paper
• Advances in bacteriophage-mediated control strategies to reduce bacterial virulence

  2021cites this paper
• Characterization of a Novel Bacteriophage Henu2 and Evaluation of the Synergistic Antibacterial Activity of Phage-Antibiotics

  2021cites this paper
• Phage therapy as strategy to face post-antibiotic era: a guide to beginners and experts

  2021cites this paper
• Aztreonam Lysine Increases the Activity of Phages E79 and phiKZ against Pseudomonas aeruginosa PA01

  2021cites this paper
• Evaluation of phage adsorption to Salmonella Typhimurium exposed to different levels of pH and antibiotic.

  2021cites this paper
• Therapeutics and delivery vehicles for local treatment of osteomyelitis

  2020cites this paper
• Bacteriophage Therapy: Developments and Directions

  2020cites this paper
• Isolation and Host Range of Lytic Staphylophages on Clinical Isolates of Methicillin-Resistant Staphylococcus aureus

  2020cites this paper
• Secondary Bacterial Infections During Pulmonary Viral Disease: Phage Therapeutics as Alternatives to Antibiotics?

  2020cites this paper
• A preliminary study of in vitro and in vivo synergistic effects of ciprofloxacin and D-tyrosine against Pseudomonas aeruginosa isolates

  2020cites this paper
• Synergistic bactericidal activity of a naturally isolated phage and ampicillin against urinary tract infecting Escherichia coli O157

  2020cites this paper
• Bacteriophage gene products as potential antimicrobials against tuberculosis.

  2019cites this paper
• Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review

  2019cites this paper
• Investigation of different interactions betweenStaphylococcus aureusphages and pomegranate peel, grape seed, and black cumin extracts

  2019cites this paper
• Combined effect of bacteriophage and antibiotic on the inhibition of the development of antibiotic resistance in Salmonella typhimurium

  2018cites this paper
• Delivering phage therapy per os: benefits and barriers

  2017cites this paper
• In vitro evaluation of an antibiofilm product: a combination between bacteriophages and Portuguese honey

  2017cites this paper
• Biomodification of abiotic surfaces for the prevention of hospital-associated infection

  2017cites this paper
• The use of phages for the removal of biofilms in the food industry

  2017cites this paper
• Improved antibacterial efficacy of bacteriophage-cosmetic formulation for treatment of Staphylococcus aureus in vitro

  2016cites this paper